SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-027574
Filing Date
2021-11-09
Accepted
2021-11-09 08:00:46
Documents
19
Period of Report
2021-11-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41704
2 logo_001.jpg GRAPHIC 5687
3 ex99-1.htm EX-99.1 945
4 ex99-1_001.jpg GRAPHIC 792611
5 ex99-2.htm EX-99.2 876
6 ex99-2_002.jpg GRAPHIC 445529
7 ex99-3.htm EX-99.3 876
8 ex99-3_003.jpg GRAPHIC 345925
  Complete submission text file 0001493152-21-027574.txt   2415658

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE lpcn-20211109.xsd EX-101.SCH 3025
10 XBRL LABEL FILE lpcn-20211109_lab.xml EX-101.LAB 34240
11 XBRL PRESENTATION FILE lpcn-20211109_pre.xml EX-101.PRE 22359
12 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3605
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 211389950
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences